Non-small Cell Lung Cancer (NSCLC), Stage IV Terminated Phase 1 Trials for Erlotinib (DB00530)

Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic

IndicationStatusPhase
DBCOND0087270 (Non-small Cell Lung Cancer (NSCLC), Stage IV)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01515969Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)Treatment